Who is eligible for CAR T-cell therapy?

Sheba’s doctors evaluate each patient to determine who is a suitable candidate for CAR T-cell therapy.

Potential patients need to have undergone at least two leukemia treatments in the past.

Currently, we provide this innovative treatment for the following diseases:

• Acute Lymphocytic Leukemia (ALL), Adult
• Non-Hodgkin’s Lymphoma (NHL), Adult and Pediatric
• Leukemia (ALL), Pediatric
• Multiple Myeloma
• Acute Myelogenous Leukemia (AML)